WallStreetZenWallStreetZen

NYSEMKT: CCEL
Cryo Cell International Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CCEL stock forecasts and price targets.

Forecast return on equity

Is CCEL forecast to generate an efficient return?

Company
-0.45%
Industry
-57.11%
Market
132.89%
CCEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CCEL forecast to generate an efficient return on assets?

Company
0.13%
Industry
9.19%
CCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CCEL earnings per share forecast

What is CCEL's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.08
Avg 2 year Forecast
$0.01

CCEL revenue forecast

What is CCEL's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$30.6M-2.03%
Avg 2 year Forecast
$29.0M-7.35%
CCEL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CCEL revenue growth forecast

How is CCEL forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
-2.03%
Industry
4.97%
Market
24.28%
CCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CCEL vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
CCEL$3.44N/AN/A
CCM$4.75N/AN/A
BMGL$0.61N/AN/A
AMS$1.35N/AN/A
NIVF$1.12N/AN/A
View Top Medical Care Facility Stocks

Cryo Cell International Stock Forecast FAQ

What is CCEL's earnings growth forecast for 2026-2027?

(NYSEMKT: CCEL) Cryo Cell International's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 11.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,315.63%.

Cryo Cell International's earnings in 2026 is -$2,665,132.On average, 3 Wall Street analysts forecast CCEL's earnings for 2026 to be $657,300, with the lowest CCEL earnings forecast at $631,524, and the highest CCEL earnings forecast at $676,633.

In 2027, CCEL is forecast to generate $82,163 in earnings, with the lowest earnings forecast at $78,940 and the highest earnings forecast at $84,579.

If you're new to stock investing, here's how to buy Cryo Cell International stock.

What is CCEL's revenue growth forecast for 2026-2027?

(NYSEMKT: CCEL) Cryo Cell International's forecast annual revenue growth rate of -2.03% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.97%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.28%.

Cryo Cell International's revenue in 2026 is $31,280,558.On average, 3 Wall Street analysts forecast CCEL's revenue for 2026 to be $246,842,017, with the lowest CCEL revenue forecast at $237,159,726, and the highest CCEL revenue forecast at $254,099,707.

In 2027, CCEL is forecast to generate $233,446,302 in revenue, with the lowest revenue forecast at $224,295,652 and the highest revenue forecast at $240,317,345.

What is CCEL's forecast return on assets (ROA) for 2026-2027?

(NYSEMKT: CCEL) forecast ROA is 0.13%, which is lower than the forecast US Medical Care Facilities industry average of 9.19%.

What is CCEL's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: CCEL) Cryo Cell International's current Earnings Per Share (EPS) is -$0.33. On average, analysts forecast that CCEL's EPS will be $0.08 for 2026, with the lowest EPS forecast at $0.08, and the highest EPS forecast at $0.08. In 2027, CCEL's EPS is forecast to hit $0.01 (min: $0.01, max: $0.01).

What is CCEL's forecast return on equity (ROE) for 2026-2027?

(NYSEMKT: CCEL) forecast ROE is -0.45%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.